Tag #Hydroxychloroquine

Showing 1 to 5 of 5 results

theguardian.com

🌐 85% Global Worthiness

May 5, 19:19

Hydroxychloroquine Advocate Appointed to Key Pandemic Prevention Role

Steven J. Hatfill, a virologist who previously promoted hydroxychloroquine as a COVID-19 treatment, has been appointed to a key pandemic prevention role at the Department of Health and Human Services, raising concerns given the drug's limited efficacy and potential side effects, as highlighted by FD...

Hydroxychloroquine Advocate Appointed to Key Pandemic Prevention Role

Steven J. Hatfill, a virologist who previously promoted hydroxychloroquine as a COVID-19 treatment, has been appointed to a key pandemic prevention role at the Department of Health and Human Services, raising concerns given the drug's limited efficacy and potential side effects, as highlighted by FD...

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What are the immediate implications of appointing a prominent hydroxychloroquine advocate to a key pandemic preparedness role, considering the drug's known risks and limited efficacy against COVID-19?

Steven J. Hatfill, a virologist who promoted hydroxychloroquine as a COVID-19 treatment despite limited evidence of its efficacy, has been appointed as a special advisor at the Department of Health and Human Services. This appointment raises concerns given the FDA's warnings about the drug's potential heart problems and its withdrawal from a medical journal. Hatfill maintains the drug's safety.

abcnews.go.com

🌐 85% Global Worthiness

Dec 19, 01:11

Retracted Hydroxychloroquine Study Highlights Risks of Premature Research and Misinformation

A 2020 study in the International Journal of Antimicrobial Agents promoting hydroxychloroquine as a COVID-19 treatment was retracted due to ethical and methodological concerns raised by the authors and the publisher, Elsevier, impacting researchers' careers and leading to the revocation of the FDA's...

Retracted Hydroxychloroquine Study Highlights Risks of Premature Research and Misinformation

A 2020 study in the International Journal of Antimicrobial Agents promoting hydroxychloroquine as a COVID-19 treatment was retracted due to ethical and methodological concerns raised by the authors and the publisher, Elsevier, impacting researchers' careers and leading to the revocation of the FDA's...

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What were the immediate consequences of the retraction of the hydroxychloroquine study, and how did it impact public health policy?

A 2020 study in the International Journal of Antimicrobial Agents promoting hydroxychloroquine as a COVID-19 treatment has been retracted due to ethical and methodological concerns, impacting researchers' careers and reputations. The retraction followed concerns about research conduct and methodology, raised by some of the authors themselves and flagged by Elsevier, the journal's publisher. The FDA's subsequent emergency use authorization for the drug was revoked after larger studies showed no benefits and potential risks.

lemonde.fr

🌐 85% Global Worthiness

Dec 17, 19:11

Retraction of Landmark Hydroxychloroquine Study for COVID-19

A study co-authored by Didier Raoult promoting hydroxychloroquine for COVID-19 treatment was retracted on December 17, 2023, by the International Journal of Antimicrobial Agents due to multiple ethical and methodological breaches, including concerns over results manipulation and lack of informed con...

Retraction of Landmark Hydroxychloroquine Study for COVID-19

A study co-authored by Didier Raoult promoting hydroxychloroquine for COVID-19 treatment was retracted on December 17, 2023, by the International Journal of Antimicrobial Agents due to multiple ethical and methodological breaches, including concerns over results manipulation and lack of informed con...

Progress

56% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What broader implications does this retraction have for scientific integrity and the processes of peer review and publication?

The retraction highlights serious flaws in the study's methodology, raising concerns about the integrity of research on COVID-19 treatments. The study's findings, which supported using hydroxychloroquine with azithromycin, were subsequently contradicted by larger, more rigorous trials demonstrating its ineffectiveness. The controversy surrounding the study extends beyond scientific circles, having involved political figures such as Emmanuel Macron and Donald Trump, who publicly endorsed the treatment.

theguardian.com

🌐 90% Global Worthiness

Dec 19, 01:10

Retraction of High-Profile Hydroxychloroquine Covid-19 Study

Elsevier retracted a March 2020 study promoting hydroxychloroquine for Covid-19 due to ethical concerns raised by three of its authors and an investigation revealing issues with patient consent and equipoise, marking the highest-cited retracted Covid-19 paper.

Retraction of High-Profile Hydroxychloroquine Covid-19 Study

Elsevier retracted a March 2020 study promoting hydroxychloroquine for Covid-19 due to ethical concerns raised by three of its authors and an investigation revealing issues with patient consent and equipoise, marking the highest-cited retracted Covid-19 paper.

Progress

48% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What long-term implications does this retraction have for the regulation of drug promotion and the conduct of future Covid-19 research?

This retraction carries significant implications for future research, emphasizing the need for robust ethical standards and rigorous methodology in clinical trials. The controversy underscores the dangers of promoting unproven treatments, especially during public health crises. The event serves as a stark reminder of the necessity of thorough peer review and the importance of transparency in scientific research.

repubblica.it

🌐 85% Global Worthiness

Dec 19, 13:11

Retraction of 2020 Hydroxychloroquine COVID-19 Study Due to Ethical and Methodological Flaws

A 2020 study promoting hydroxychloroquine for COVID-19 treatment, published in the International Journal of Antimicrobial Agents and led by Philippe Gautret, has been retracted due to ethical concerns and methodological flaws, including a small sample size and issues with patient consent for azithro...

Retraction of 2020 Hydroxychloroquine COVID-19 Study Due to Ethical and Methodological Flaws

A 2020 study promoting hydroxychloroquine for COVID-19 treatment, published in the International Journal of Antimicrobial Agents and led by Philippe Gautret, has been retracted due to ethical concerns and methodological flaws, including a small sample size and issues with patient consent for azithro...

Progress

52% Bias Score

ShareSaveArticle

Good Health and Well-being

12345678

Previous 1 of 8 Next

What were the key methodological and ethical flaws in the retracted 2020 study on hydroxychloroquine's efficacy against COVID-19, and what were the immediate consequences of its promotion?

In 2020, a study in the International Journal of Antimicrobial Agents (IJAA) promoted hydroxychloroquine for COVID-19 treatment. This study, led by Philippe Gautret, has now been retracted due to ethical concerns and methodological flaws, including a small sample size of only 36 patients and irregularities in ethical approval and patient consent regarding the use of azithromycin. The retraction follows years of criticism highlighting these issues and potential ethical violations.

Showing 1 to 5 of 5 results